Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: ECI grants in MRC&Y Health - NMHA

University of Calgary

$105,000.00

Changing the face of pediatric migraine: A phase 2a randomized controlled trial of a novel neuromodulation device for refractory acute migraine in children and adolescents

FY 2020-21

Summary
One in ten children and adolescents suffer from migraine. Children and adolescents with migraine often come to the emergency department (ED) with acute attacks of migraine, with over 2,500 pediatric ED visits for migraine yearly in Alberta alone. Despite this, there is little evidence on how to treat migraine in children and adolescents in the ED. The evidence is limited to intravenous (IV) interventions, which are associated with high complication rates, costs, and patient fears about pain. There are 3 innovative, electrical stimulation/neuromodulation devices that safely and effectively treat adults with acute attacks of migraine. We hosted a patient engagement session to discuss these devices with a group of Canadian adolescents with chronic headaches to understand which device they would be most interested in trying to treat an acute migraine attack in the ED. The majority of the group were most interested in trying the remote electrical neuromodulation (REN) device. We will design a research study to determine if the REN device is safe and effective in treating children and adolescents who are suffering from an acute attack of migraine in the ED. The study has been designed with feedback from patients and ED health care professionals. Our initial goal is to recruit 40 children and adolescents who are visiting the ED and are suffering an acute attack of migraine, to see if the study is feasible and acceptable. These participants will randomly be given either the REN device or a combination of typical IV medications used to treat migraine attacks in the ED; each participant will also receive a placebo treatment (either a placebo/saline IV fluid if given the REN treatment, or a sham/fake REN device if given the typical IV medications). Participants and staff will not be aware which group they are in. This work has the potential to revolutionize the care of children and adolescents coming to the ED with acute attacks of migraine by expanding treatment options.
Program
Operating Grant: ECI grants in MRC&Y Health - NMHA
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449077
Name
Orr Serena L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Operating Grant: New Investigator Grants in Maternal, Reproductive, Child & Youth Health
Projecttitle
Changing the face of pediatric migraine: A phase 2a randomized controlled trial of a novel neuromodulation device for refractory acute migraine in children and adolescents
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Operating Grant: ECI grants in MRC&Y Health - NMHA
Keyworddelim
Emergency Department; Neuromodulation; Pediatric Migraine; Randomized Controlled Trial; Treatment
Abstract
One in ten children and adolescents suffer from migraine. Children and adolescents with migraine often come to the emergency department (ED) with acute attacks of migraine, with over 2,500 pediatric ED visits for migraine yearly in Alberta alone. Despite this, there is little evidence on how to treat migraine in children and adolescents in the ED. The evidence is limited to intravenous (IV) interventions, which are associated with high complication rates, costs, and patient fears about pain. There are 3 innovative, electrical stimulation/neuromodulation devices that safely and effectively treat adults with acute attacks of migraine. We hosted a patient engagement session to discuss these devices with a group of Canadian adolescents with chronic headaches to understand which device they would be most interested in trying to treat an acute migraine attack in the ED. The majority of the group were most interested in trying the remote electrical neuromodulation (REN) device. We will design a research study to determine if the REN device is safe and effective in treating children and adolescents who are suffering from an acute attack of migraine in the ED. The study has been designed with feedback from patients and ED health care professionals. Our initial goal is to recruit 40 children and adolescents who are visiting the ED and are suffering an acute attack of migraine, to see if the study is feasible and acceptable. These participants will randomly be given either the REN device or a combination of typical IV medications used to treat migraine attacks in the ED; each participant will also receive a placebo treatment (either a placebo/saline IV fluid if given the REN treatment, or a sham/fake REN device if given the typical IV medications). Participants and staff will not be aware which group they are in. This work has the potential to revolutionize the care of children and adolescents coming to the ED with acute attacks of migraine by expanding treatment options.
Competitiondate
202102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Orr, Serena L
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $105,000~ $0~
University of Calgary - $105,000 Grant (2020-21) | Canada Spends